The Patent Finder

Dermavant Sciences GmbH

20 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Dec 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 13, 2027
    The maintenance fee for Novel Method of Use (US 10,376,475) comes due Feb 13, 2027. Unpaid by Aug 13, 2027, it lapses early.
  • 1 fee due Apr 1, 2027
    The maintenance fee for Topical Pharmaceutical Compositions (US 10,426,743) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
  • 1 fee due May 28, 2027
    The maintenance fee for ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR IMBALANCE (US 11,827,605) comes due May 28, 2027. Unpaid by Nov 29, 2027, it lapses early.
  • 1 fee due Sep 26, 2027
    The maintenance fee for Use of Tapinarof for the Treatment of Atopic Dermatitis (US 11,938,099) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
  • 1 fee due Nov 12, 2027
    The maintenance fee for Process for Preparing Tapinarof (US 10,647,649) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,376,475Novel Method of Use
In force
 · High confidence
In forceHigh confidence
US 10,426,743Topical Pharmaceutical Compositions
In force
 · High confidence
In forceHigh confidence
US 11,458,108Topical Pharmaceutical Compositions
In force
 · High confidence
In forceHigh confidence
US 11,612,573Topical Pharmaceutical Compositions
In force
 · High confidence
In forceHigh confidence
US 11,617,724Topical Pharmaceutical Compositions
In force
 · High confidence
In forceHigh confidence
US 11,622,945Topical Pharmaceutical Compositions
In force
 · High confidence
In forceHigh confidence
US 10,195,160Topical Pharmaceutical Compositions
In force
 · High confidence
In forceHigh confidence
US 10,206,925Topical Formulations of PDE-4 Inhibitors and Their Methods of Use
In force
 · High confidence
In forceHigh confidence
US 10,647,649Process for Preparing Tapinarof
In force
 · High confidence
In forceHigh confidence
US 10,961,175Process for Preparing Tapinarof
In force
 · High confidence
In forceHigh confidence
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
Also on record, not counted in the 20: 1 lapsed for an unpaid fee · 3 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 pending · 3 abandoned · 5 no status recorded

Showing 1 to 10 of 15, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/077,700Process for Preparing TapinarofMar 12, 2025Pending
19/053,643ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR IMBALANCEFeb 14, 2025Pending
18/643,595Topical Pharmaceutical CompositionsApr 23, 2024Abandoned
18/066,945Topical Pharmaceutical CompositionsDec 15, 2022Pending
17/820,692Remittive Effects of Tapinarof in the Treatment of Plaque Psoriasis, Atopic Dermatitis, or Radiation DermatitisAug 18, 2022Pending
17/734,877May 2, 2022No status recorded
18/546,880Remittive Effects of Tapinarof in the Treatment of Plaque Psoriasis, Atopic Dermatitis, or Radiation DermatitisFeb 17, 2022Pending
17/674,577Remittive Effects of Tapinarof in the Treatment of Plaque Psoriasis, Atopic Dermatitis, or Radiation DermatitisFeb 17, 2022Abandoned
17/533,885Gel, Ointment, and Foam Formulations of Tapinarof and Methods of UseNov 23, 2021Pending
18/002,511Topical Pharmaceutical CompositionsJun 24, 2021Pending
10 of 15 applications shown.
Pro members see all 15 published applications.
Pro members: see all 15 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited